A multiscale view of therapeutic protein aggregation: a colloid science perspective

Biotechnology Journal
Lucrèce NicoudMassimo Morbidelli

Abstract

The formation of aggregates in protein-based pharmaceuticals is a major issue that can compromise drug safety and drug efficacy. With a view to improving protein stability, considerable effort is put forth to unravel the fundamental mechanisms underlying the aggregation process. However, therapeutic protein aggregation is a complex multistep phenomenon that involves time and length scales spanning several orders of magnitude, and strategies addressing protein aggregation inhibition are currently still largely empirical in practice. Here, we review how key concepts developed in the frame of colloid science can be applied to gain knowledge on the kinetics and thermodynamics of therapeutic protein aggregation across different length scales. In particular, we discuss the use of coarse-grained molecular interaction potentials to quantify protein colloidal stability. We then show how population balance equations simulations can provide insights into the mechanisms of aggregate formation at the mesoscale, and we highlight the strength of the concept of fractal scaling to quantify irregular aggregate morphologies. Finally, we correlate the macroscopic rheological properties of protein solutions with the occupied volume fraction and the...Continue Reading

References

Nov 1, 1969·European Journal of Biochemistry·G H BeavenH G Davies
Feb 15, 1997·Journal of Colloid and Interface Science·C M Sorensen, G C Roberts
Oct 28, 1998·Biophysical Journal·B L NealA M Lenhoff
Feb 28, 2002·Biophysical Journal·Peter M TessierStanley I Sandler
Apr 27, 2002·Nature·V J Anderson, H N W Lekkerkerker
Oct 9, 2002·Current Protein & Peptide Science·S M Kelly, N C Price
Apr 12, 2003·Advances in Colloid and Interface Science·Marco LattuadaMassimo Morbidelli
Apr 30, 2003·Protein Science : a Publication of the Protein Society·Eva Y ChiTheodore W Randolph
Aug 15, 2003·Nature·Fabrizio ChitiChristopher M Dobson
Apr 10, 2004·Advances in Colloid and Interface Science·Peter SandkühlerMassimo Morbidelli
May 5, 2004·Journal of Pharmaceutical Sciences·Steven J ShireJun Liu
Sep 4, 2004·Biophysical Journal·Brian M Baynes, Bernhardt L Trout
Jan 18, 2005·International Journal of Pharmaceutics·Wei Wang
Apr 2, 2005·Nature Reviews. Drug Discovery·Sven Frokjaer, Daniel E Otzen
Jun 9, 2006·Angewandte Chemie·Wilfred F van GunsterenHaibo B Yu
Dec 22, 2006·The Journal of Physical Chemistry. B·Jedrzej SzymańskiRobert Holyst
Apr 17, 2007·Trends in Biotechnology·Troy CellmerHarvey W Blanch
Jun 19, 2007·The Journal of Physical Chemistry. B·Jennifer M Andrews, Christopher J Roberts
Aug 21, 2007·Biotechnology and Bioengineering·Christopher J Roberts
Oct 13, 2007·Archives of Biochemistry and Biophysics·Rohit V PappuScott L Crick
Jan 4, 2008·Pharmaceutical Research·Andrea HaweWim Jiskoot
Aug 8, 2008·Journal of Pharmaceutical Sciences·William F WeissChristopher J Roberts
Mar 14, 2009·Biochimica Et Biophysica Acta·Søren N OlsenPeter Westh
May 29, 2009·Journal of Pharmaceutical Sciences·Branden A SalinasTheodore W Randolph
Jul 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Naresh ChennamsettyBernhardt L Trout
Dec 17, 2009·Science·Tuomas P J KnowlesChristopher M Dobson
Mar 5, 2010·Biophysical Chemistry·Jose M Sanchez-Ruiz
Apr 24, 2010·The Journal of Physical Chemistry. B·Naresh ChennamsettyBernhardt L Trout
Sep 14, 2010·Journal of Colloid and Interface Science·Yogesh M HarsheMarco Lattuada
Sep 21, 2010·The Journal of Physical Chemistry. B·Thomas M SchererAllen P Minton
Feb 5, 2011·Journal of Pharmaceutical Sciences·Christian LehermayrStefan Fischer
Feb 12, 2011·Biotechnology Progress·Rachael A LewusStanley I Sandler
Feb 19, 2011·Physical Chemistry Chemical Physics : PCCP·Emanuela BianchiChristos N Likos
Mar 31, 2011·Pharmaceutical Research·Paolo ArosioMassimo Morbidelli
Apr 12, 2011·Biotechnology and Bioengineering·María Vázquez-Rey, Dietmar A Lang
Apr 19, 2011·International Journal of Pharmaceutics·Christopher J RobertsErinc Sahin
Jul 16, 2011·Advanced Drug Delivery Reviews·Satoshi OhtakeTsutomu Arakawa
Jul 19, 2011·Advanced Drug Delivery Reviews·Diwakar ShuklaBernhardt L Trout

❮ Previous
Next ❯

Citations

Jan 15, 2016·Analytical Biochemistry·Damien HallJohn A Carver
Nov 19, 2015·Journal of Pharmaceutical Sciences·Carmen R M BriaSiriwan Kim Ratanathanawongs Williams
Feb 26, 2015·Biotechnology Journal·Marina Lotti, Francesco Secundo
Mar 24, 2016·The Journal of Physical Chemistry. B·Lucrèce NicoudMassimo Morbidelli
Aug 19, 2016·The Journal of Physical Chemistry. B·Hiroshi Imamura, Shinya Honda
Nov 30, 2016·Journal of Pharmaceutical Sciences·Teddy J ZbacnikMark Cornell Manning
May 3, 2018·Protein Science : a Publication of the Protein Society·Diana GomesChristopher J Roberts
Jun 11, 2015·Soft Matter·Lucrèce NicoudMassimo Morbidelli
Aug 24, 2017·Protein Science : a Publication of the Protein Society·Michal NemergutErik Sedlák
Mar 11, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sarah L Perry, David Julian McClements
Nov 16, 2019·International Journal of Biological Macromolecules·Sepideh Haghighi-PoodehAzadeh Ebrahim-Habibi
Jun 20, 2021·Biomolecular Concepts·Rohit BansalNiraj Kumar Jha
Jul 6, 2021·Journal of Molecular Biology·Roy NassarKen A Dill
Mar 20, 2019·Analytical Chemistry·Yukako SengaShinya Honda
Jul 15, 2020·The Journal of Physical Chemistry Letters·Kevin PounotTilo Seydel
Oct 9, 2021·Soft Matter·Kathleen T LauserMichelle A Calabrese

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics
T SintesA Chakrabarti
Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics
B K JohnsonM P Foley
Advances in Colloid and Interface Science
P Meakin
© 2021 Meta ULC. All rights reserved